Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Collegium Pharmaceutical (COLL) Other Non Operating Income: 2016-2024

Historic Other Non Operating Income for Collegium Pharmaceutical (COLL) over the last 2 years, with Sep 2024 value amounting to -$4.1 million.

  • Collegium Pharmaceutical's Other Non Operating Income was N/A to -$4.1 million in Q3 2024 from the same period last year, while for Sep 2024 it was -$27.5 million, marking a year-over-year change of. This contributed to the annual value of -$11.3 million for FY2024, which is 51.80% up from last year.
  • As of Q3 2024, Collegium Pharmaceutical's Other Non Operating Income stood at -$4.1 million, which was up 91.18% from -$47.0 million recorded in Q2 2023.
  • Over the past 5 years, Collegium Pharmaceutical's Other Non Operating Income peaked at $23.5 million during Q1 2023, and registered a low of -$47.0 million during Q2 2023.
  • Moreover, its 2-year median value for Other Non Operating Income was -$4.1 million (2024), whereas its average is -$9.2 million.